Education & Professional Experience

Kyle has studied at The Wharton School of Business, University of Pennsylvania in Strategy, Finance between 1998 and 2000, then at Wesleyan University in College of Social Studies between 1986 and 1990.

Kyle worked for Independent Consultant as Corporate Strategy, Business Development and Financing Consultant between Sep 2017 and Sep 2018, for Syros Pharmaceuticals as Chief Operating Officer between Sep 2015 and Sep 2017, for Blueprint Medicines as Chief Business Officer between Sep 2013 and Sep 2015, for Millennium Pharmaceuticals: The Takeda Oncology Company as Vice President, Corporate Strategy and Development between Mar 2002 and Sep 2013, for Pfizer as Summer Intern between 1999 and 1999, for TQM Group / Spire as Consultant between 1993 and 1995.